These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3262103)

  • 1. Synthesis and beta-lactamase inhibitory activity of 9-(2-amidoethenylthio)-9-deoxy derivatives of clavulanic acid.
    Brooks G; Coleman K; Davies JS; Hunter PA
    J Antibiot (Tokyo); 1988 Jul; 41(7):892-8. PubMed ID: 3262103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues.
    Mak CP; Prasad K; Turnowsky F
    J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric studies on the inhibition of TEM-2 beta-lactamase by clavulanic acid derivatives.
    Brown RP; Aplin RT; Schofield CJ; Frydrych CH
    J Antibiot (Tokyo); 1997 Feb; 50(2):184-5. PubMed ID: 9099233
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and action of clavulanic acid.
    Cole M
    Scott Med J; 1982; 27 Spec No.():S10-6. PubMed ID: 6762660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases.
    Vanwetswinkel S; Fastrez J; Marchand-Brynaert J
    J Antibiot (Tokyo); 1994 Sep; 47(9):1041-51. PubMed ID: 7928692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
    Reading C; Farmer T; Cole M
    J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semi-empirical study of some clavulanic acid derivatives in relation to their activity as beta-lactamase inhibitors.
    Fernández B; Ríos MA
    J Pharm Pharmacol; 1993 Jan; 45(1):25-9. PubMed ID: 8094441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content.
    Kitzis MD; Gutmann L; Acar JF
    J Antimicrob Chemother; 1985 Jan; 15(1):23-30. PubMed ID: 3882654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis.
    Fields PI; Schreier HJ; Saha AL; Bernlohr RW
    J Bacteriol; 1984 Aug; 159(2):803-4. PubMed ID: 6086590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity.
    Martín M; Aguilar L; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
    J Antimicrob Chemother; 1997 Feb; 39(2):290-2. PubMed ID: 9069559
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.
    Farmer T; Reading C
    Drugs; 1986; 31 Suppl 3():70-8. PubMed ID: 3488199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
    Micetich RG; Maiti SN; Spevak P; Hall TW; Yamabe S; Ishida N; Tanaka M; Yamazaki T; Nakai A; Ogawa K
    J Med Chem; 1987 Aug; 30(8):1469-74. PubMed ID: 3039137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of clavulanate and tazobactam on Peptostreptococcus spp.
    Reig M; Baquero F
    J Antimicrob Chemother; 1994 Feb; 33(2):358-9. PubMed ID: 8182024
    [No Abstract]   [Full Text] [Related]  

  • 18. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy of clavulanic acid with benzylpenicillin or cephalothin against Yersinia spp.
    Jimenez-Valera M; Ruiz-Bravo A; Ramos-Cormenzana A
    J Antimicrob Chemother; 1987 Jun; 19(6):845-7. PubMed ID: 3497153
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
    Hedberg M; Lindqvist L; Tunér K; Nord CE
    J Antimicrob Chemother; 1992 Jul; 30(1):17-25. PubMed ID: 1331018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.